Torrent Pharmaceuticals rescheduled its investor conference call to discuss Q4 and FY26 financial results from 6:30 PM to 5:30 PM on May 22, 2026.
The company will discuss financial performance for the quarter and year ended March 31, 2026 with investors and analysts.
Dial-in details and Diamond Pass registration link remain unchanged from the original May 12, 2026 announcement.